ESTRO 2025 - Abstract Book

S218

Brachytherapy - Gynaecology

ESTRO 2025

Conclusion: The proposed dose planning aims of the RAPID study for different GTV-T res volumes, locations and applicators are feasible in high proportion of favorable-risk cervical cancer patients. Achievability of soft constraints can be further improved with increased use of advanced IC-IS applicators.

Keywords: Favourable-risk cervical cancer, feasibility,RAPID

References: 1 Serban M, Gallois M, Urtubey T, Nout R, de Leeuw A, Fokdal L, Assenholt M, Spampinato S, Bruheim K, Segedin B, Chopra S. OC-0503 Effect of dose and fractionation de-escalation in low-risk cervix cancer treated with EBRT and BT. Radiotherapy and Oncology. 2022 May 1;170:S451-3.

711

Digital Poster Evaluating Dosimetric Stability and feasibility of Single-Application HDR Brachytherapy for Cervical Cancer

Marie Bruand 1 , Jean-François Py 1 , Sophie Renard 1 , Claire Charra-Brunaud 1 , Emilie Meknaci 2 1 Radiotherapy, Institut de Cancérologie de Lorraine, Nancy, France. 2 Physics, Institut de Cancérologie de Lorraine, Nancy, France